Evidence map›Paper›PMID 41709867›Full record

ArticleActa crystallographica. Section D, Structural biology2026

Breaking barriers: transitioning from X-ray crystallography to cryo-EM for structural studies.

Hassan Zafar, Kiera L Malone, Ajit K Singh, Michael A Cianfrocco, Karen C Glass

Abstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Hassan ZafarDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
Kiera L MaloneDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
Ajit K SinghDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
Michael A CianfroccoLife Sciences Institute, Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0002-2067-4999
Karen C GlassDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Julie Dragon · 2012 to 2026
$58.4M
NCCAT: National Center for CryoEM Access and Training- Supplement for Windows 10 and FFIU24GM129539 · NIGMS · NEW YORK STRUCTURAL BIOLOGY CENTER · PI DE MARCO, ALEX, KIEFT, JEFFREY S · 2018 to 2023
$53.9M
TLR-TRIF mediated induction of GLI3 modulates innate inflammatory responsesP20GM113131 · NIGMS · UNIVERSITY OF NEW HAMPSHIRE · PI Sean Stoddart Coleman Edington · 2017 to 2026
$22.8M
NCCAT: National Center for CryoEM Access and TrainingR24GM154192 · NIGMS · NEW YORK STRUCTURAL BIOLOGY CENTER · PI EDWARD T ENG, Jeffrey S Kieft · 2024 to 2026
$21.0M
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast CancerP01CA240685 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI STEIN, JANET L · 2021 to 2025
$8.7M
UVM Center for Biomedical Shared Resources (CBSR)C06OD030087 · OD · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TAATJES, DOUGLAS J. · 2020 to 2020
$5.5M
Deciphering the molecular mechanisms of histone code recognition by ATAD2/BR01GM129338 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI FRIETZE, SETH E, GLASS, KAREN CHAMPAGNE · 2018 to 2022
$2.1M
American Heart Association 24POST1194310National Institutes of Health, National Cancer Institute P01CA240685National Institutes of Health, National Institute of General Medical Sciences P20GM113131-07S1National Institutes of Health, National Institute of General Medical Sciences R01GM129338National Institutes of Health, National Institute of General Medical Sciences R24GM154192National Institutes of Health, National Institute of General Medical Sciences U24GM129539National Institutes of Health, NIH Office of the Director 1C06OD030087-01National Science Foundation, Directorate for Biological Sciences 1827314National Science Foundation, Directorate for Biological Sciences 2321501National Science Foundation, Directorate for Biological Sciences 2510406NCI NIH HHS P01 CA240685NIGMS NIH HHS P20 GM103449NIGMS NIH HHS P20 GM113131NIGMS NIH HHS R01 GM129338NIGMS NIH HHS R24 GM154192NIGMS NIH HHS U24 GM129539NIH HHS C06 OD030087Simons Foundation SF349247
6 · The paper itself

Abstract

Cryo-electron microscopy (cryo-EM) has transformed structural biology by enabling near-atomic resolution of large macromolecular complexes without the need for crystallization. Here, we describe our laboratory's transition from X-ray crystallography to single-particle cryo-EM to investigate the ATPase family AAA+ domain-containing protein 2B (ATAD2B), a chromatin regulator implicated in epigenetic signaling. We outline the challenges encountered during protein expression, purification and sample preparation, including co-purification of the chaperonin GroEL, and the strategies employed to overcome these obstacles. Our workflow highlights critical steps in sample optimization, grid vitrification and data processing using CryoSPARC, cisTEM and Topaz, as well as computational requirements for high-resolution reconstructions. We also discuss model-building, refinement and validation approaches, emphasizing best practices for new cryo-EM users. This work provides practical insights for structural biologists adopting cryo-EM, particularly for large, flexible protein complexes, and underscores the importance of integrated approaches combining biochemical, computational and imaging strategies.

Indexed as

Cryoelectron MicroscopyDNA-Binding ProteinsChaperonin 60Crystallography, X-RayModels, MolecularProtein ConformationChaperonin 60DNA-Binding ProteinsATAD2Bbromodomainscryo-electron microscopydata-processing workflowsGroELmacromolecular X-ray crystallographymodel building and refinementprotein expression and purificationsingle-particle analysisstructural biology

Identifiers

PMID41709867
PMCPMC12954864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.